What is Semaglutide?
Originally developed as a treatment for diabetes, Semaglutide has emerged as a game-changer in weight management. This GLP-1 medication targets crucial appetite-regulating centers in the brain, effectively curbing cravings, reducing body mass index, and supercharging metabolism.
Semaglutide mimics the effects of Glucagon-like Peptide-1 (GLP-1), exerting precise control over appetite while mitigating overeating tendencies. Semaglutide minimizes gastrointestinal side effects through a carefully calibrated dosage regimen spanning 16 to 20 weeks, ensuring a safe and sustainable approach to long-term weight management.
While Semaglutide boasts an impressive success rate of 99% among our patients, we understand that individual needs vary. For those seeking alternatives or for whom Semaglutide may not be the optimal fit, we proudly offer Tirzepatide (Mounjaro).